Watch CBS News

Food and Drug Administration

cbsn-fusion-covid-vaccine-johnson-and-johnson-side-effects-dr-taison-bell-analysis-thumbnail-692069-640x360.jpg

States halting use of Johnson & Johnson vaccine

All 50 states are halting use of Johnson and Johnson's coronavirus vaccine after at least six women developed blood clots. As CBS News' Jericka Duncan reports, the FDA and the CDC recommended a temporary pause to investigate these cases out of an "abundance of caution." Dr. Taison Bell, a critical care and infectious disease physician and the medical ICU director at the University of Virginia, joins CBSN's Elaine Quijano to discuss the latest.

cbsn-fusion-coronavirus-vaccine-johnson-and-johnson-clotting-issue-analysis-dr-julie-morita-thumbnail-691821-640x360.jpg

How big of a concern is the J&J clotting issue?

The Biden administration says that pausing the distribution of Johnson & Johnson's coronavirus vaccine should not hamper the nation's ongoing vaccine efforts. As CBS News' Skyler Henry reports, the announcement comes as the U.S. calls to pause the distribution of the Johnson & Johnson vaccine after receiving reports that at least six women had suffered a rare blood-clotting disorder after getting their shot. Dr. Julie Morita, a former member of the Biden administration transition advisory board and the executive vice president of the Rober Wood Johnson Foundation, joins CBSN's Tanya Rivero to discuss the impact the pause could have on the nation's vaccine efforts.

1112-ctm-werner-artificialingriedients-466163-640x360.jpg

The Food and Drug Administration is asking for your thoughts on how to define the term "natural" on food labels

The Food and Drug Administration is asking for your thoughts on how to define the term "natural" on food labels. The government opened a 90-day comment period, after increasing demands from people for more transparency about what we're eating. Some major food companies say they're already swapping artificial ingredients for more natural alternatives, but some food experts warn there’s still a long way to go in regulating what goes into our food. Anna Werner reports.

ctm23andme-1021-458607-640x360.jpg

The FDA wrote a scathing warning letter ordering 23andMe to halt sales and stop giving customers a health analysis

Two years ago, the company 23andMe was poised to revolutionize personal genetic medicine. With a $99 saliva kit, it offered to analyze your DNA, revealing your risk for health threats like diabetes, heart disease and breast cancer. The FDA wrote a scathing warning letter ordering 23andMe to halt sales and stop giving customers a health analysis. The feds claimed 23andMe wouldn’t cooperate and ignored inquiries for six months. CEO and co-founder of “23 and Me” Anne Wojcicki joins “CBS This Morning" to discuss the company's future.

ctm-0819-pink-pill-434867-640x360.jpg

It is a pill designed for pre-menopausal women with hypoactive sexual desire disorder, or a decreased sexual desire

The first prescription drug to boost women's sex drives is set to launch this fall. The FDA approved Addyi Tuesday after years of debate. It is a pill designed for pre-menopausal women with hypoactive sexual desire disorder, or a decreased sexual desire. It is the most common form of sexual dysfunction in women. Vinita Nair reports on why the pink pill comes with a dose of controversy.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue